First Allied Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
2020
Q2
$229K Buy
2019
Q3
Sell
2019
Q2
$264K Sell
2019
Q1
$281K Buy
2018
Q1
Sell
2017
Q4
$224K Buy
2017
Q3
$229K Buy
2017
Q2
$225K Hold
2017
Q1
$212K Sell
2016
Q4
$209K Sell
2016
Q3
$269K Buy